213
Nius atikol i ken kamap:
NewCGX i mekim na ol dokta i no inap kisim sik long rot bilong Imaging Teknoloji
NewCGX, wanpela kampani i stap long Kalifonia i save wok long medikol imejing na wok painimaut, i bin kirapim wanpela nupela pletfom we i promis long kamapim gutpela na gutpela wok bilong klinikel intelijen (AI) na dip lening algorithm. pletfom, ol i kolim NewCGX Visen, i bungim ol kain kain rot bilong wokim ol samting bilong wokim ol piksa, olsem X-rei, MRI, CT, na ultrasaun, CT, na ultrasaun, na ol i yusim ol gutpela samting bilong ol yet, olsem X-rei, MRI, CT, na ultrasaun, . ol sikman.
Folem NewCGX Faunda mo CEO, Dr. Peter Wang, Visen i ripresentem wan bigfala lip i go fored long teknoloji blong medikol imejing teknoloji, from se i save faenem ol samting we i no stret mo ol paten we ae blong man i save mestem o oli no lukluk long . ia . klaud kompyuting, mipela inap long skelim ol bikpela mak bilong ol piksa data long ril-taim na givim ol eksen ol i ken mekim wok long en we inap strongim daignosis, tritmen plening na monitoring."
Wanpela bilong ol bikpela samting bilong Visen em inap bilong em long prosesim planti ol piksa modalitis long wankain taim na bungim ol i go insait long wanpela kohesiv 3D model. Dispela i min olsem ol dokta i ken skelim na koreletim ol narapela narapela lukluk bilong anatomi na fisioloji bilong sikman, na painim ol anomali o senis long taim we inap soim sik i go het o bekim long taim we inap soim sik i go het o bekim long taim we inap soim sik i go het o bekim long terapi.....’," elastisiti, we i save help blong mekem ol sua we oli no nogud mo ol nogud lesen, estimet prognosis, mo gaedem ol stret terapi blong presis.
Another advantage of Vision is its intuitive and interactive interface, which allows doctors and patients to navigate and explore the imaging data in a user-friendly way. For instance, doctors can zoom in and out, rotate or slice the 3D model, and annotate or highlight specific regions of interest, while patients can view their own data and learn more about their condition and treatment options. Vision also supports secure and seamless data sharing and collaboration among ol heltke provaida, we i save impruvum komunikesen mo kodinesen long ol kompleks kes.
NewCGX has already tested and validated Vision in several clinical settings, including oncology, cardiology, neurology, and orthopedics, and has received positive feedback from users. For instance, Dr. Amanda Chang, a radiologist at Stanford Hospital, praises Vision for its ability to reveal hidden features of tumors and assist in treatment planning. "With Vision, I can see things that were not visible bipo, na mekim ol disisen i gat gutpela save moa long baiopsi, operesen, o rediesen terapi," Dokta. Chang. "Em i save sevim taim na daunim ol asua, na long pinis bilong en i save mekim ol autkam bilong ol sikman i kamap gutpela."
NewCGX plans to expand the application of Vision to other areas of medicine, such as pediatrics, geriatrics, and preventive health, and to integrate more advanced AI algorithms, such as natural language processing and predictive analytics, into the platform. The company also aims to collaborate with academic and industry partners to further validate and refine the technology, and to obtain regulatory approval from the FDA and other agencies. With its vision for a heltke sistem we data i draevem mo blong mekem i stret long man, NewCGX i hop blong lidim wan niu wev blong inovasen long saed blong medikol imaging mo faenemaot sik blong .